YIJIAHE(SH:603666)2025-01-17 09:30Financial Performance - The company expects a net profit attributable to shareholders of approximately -195 million yuan for the year 2024, indicating a loss [3]. - The expected net profit attributable to shareholders, after deducting non-recurring gains and losses, is approximately -188 million yuan for 2024 [3]. - In 2023, the company reported a total profit of -21.98 million yuan, with a net profit attributable to shareholders of -10.06 million yuan [5]. Investment Impact - The company faced a significant investment loss of approximately 49 million yuan from its associate, Tadao Medical Technology Co., which heavily impacted profits [6]. Strategic Focus - The company is actively pursuing a "robot + industry" development strategy, focusing on advanced technologies such as embodied intelligence and AI [6]. Expense Management - The overall expense ratio remains high, affecting the company's profitability despite ongoing management optimization efforts [6]. - The company has increased provisions for bad debts due to poor collection of long-aged receivables, further impacting profits [6]. Caution for Investors - The preliminary financial data is subject to final confirmation in the official 2024 annual report, and investors are advised to be cautious [8].